PDF《2018》

13 June

2019 Shenzhen Neptunus Interlong Bio-technique Company Limited

6 Environmental, Social and Governance Report

3 Corporate Operation and Development 3.1 About Neptunus Interlong Introduction to the Enterprise The Company was established in 1994, and listed on GEM of The Stock Exchange (Stock Code: 8329) in September 2005. The controlling shareholder of the Company is Shenzhen Neptunus Bio-engineering Company Limited, a joint stock limited company incorporated and domiciled in the PRC and its shares are listed on the main board of Shenzhen Stock Exchange (Stock Code: 000078). The Company is a pharmaceutical and healthcare company and it seized opportunities in the fast-growing pharmaceutical market in China. Its businesses cover several important links in the pharmaceutical and healthcare industrial chain, which make contributions to the health of the populace in research and development, pharmaceutical manufacturing and distribution. The Group is principally engaged in the research and development, manufacturing and selling of medicines, and the purchase and sales of medicines and healthcare food products in the PRC. The medicines being sold by the Group mainly cover four therapeutic areas which are oncology, cardiovascular system, respiratory system and digestive system. The Group manufactures its own medicines through its production base ( Fuz........